Le, Trung | Engineering Papers

DOE OSTI2023

Virtual Flow Solver - Geophysics: A 3D Incompressible Navier-Stokes Solver

Virtual Flow Solver - Geophysics (VFS-Geophysics) is a three-dimensional (3D) incompressible Navier-Stokes solver based on the Curvilinear Immersed Boundary (CURVIB) method. The CURVIB is a sharp interface type of immersed boundary (IB) method that enables the simulation of fluid flows in the presence of geometrically complex moving bodies. The CURVIB method can be applied to wind/MHK turbine simulations and energy applications. VFS-Geophysics is the result of many years of research work by several graduate students, post-docs, and research associates that have been involved in the Computational Hydrodynamics and Biofluids Laboratory directed by Professor Fotis Sotiropoulos. The preparation of the present manual has been supported by the U.S. Department of Energy (DE-EE 0005482).

16 TIDAL AND WAVE POWER↗

DOE OSTI2023

FDX1-dependent and independent mechanisms of elesclomol-mediated intracellular copper delivery

Recent studies have uncovered the therapeutic potential of elesclomol (ES), a copper-ionophore, for copper deficiency disorders. However, we currently do not understand the mechanism by which copper brought into cells as ES–Cu(II) is released and delivered to cuproenzymes present in different subcellular compartments. Here, we have utilized a combination of genetic, biochemical, and cell-biological approaches to demonstrate that intracellular release of copper from ES occurs inside and outside of mitochondria. The mitochondrial matrix reductase, FDX1, catalyzes the reduction of ES–Cu(II) to Cu(I), releasing it into mitochondria where it is bioavailable for the metalation of mitochondrial cuproenzyme— cytochrome c oxidase. Consistently, ES fails to rescue cytochrome c oxidase abundance and activity in copper-deficient cells lacking FDX1. In the absence of FDX1, the ES-dependent increase in cellular copper is attenuated but not abolished. Thus, ES-mediated copper delivery to nonmitochondrial cuproproteins continues even in the absence of FDX1, suggesting alternate mechanism(s) of copper release. Importantly, we demonstrate that this mechanism of copper transport by ES is distinct from other clinically used copper-transporting drugs. Our study uncovers a unique mode of intracellular copper delivery by ES and may further aid in repurposing this anticancer drug for copper deficiency disorders.

59 BASIC BIOLOGICAL SCIENCES↗